Chemo-Pharma Laboratories Inc. (CPL)
BSE
Real-time Data
03:45 AM
Day's Range
64.5052 wk Range
52.67Overview - CPL - Chemo-Pharma Laboratories Inc.
Key Statistics
Valuation
Enterprise Value
4.86B
P/E (Trailing)
‪13.86‬
Price / Sales (TTM)
‪0.93‬
Price / Book
‪2.07‬
EV / EBITDA
‪10.62‬
Profitability
Gross Margin
‪26.45%‬
Profit Margin
‪6.56%‬
Operating Margin
‪10.59%‬
Return on Assets
‪7.99%‬
Return on Equity
‪14.51%‬
Ownership
Shares Outstanding
60.17M
Float
17.74M
Held by Insiders
‪70.34%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.62‬
50-Day Avg
‪70.90‬
200-Day Avg
‪73.08‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Annual
Market Cap - CPL - Chemo-Pharma Laboratories Inc.
Peers - CPL - Chemo-Pharma Laboratories Inc.
Peer Comparison
Compared with companies in Farm & Heavy Construction Machinery listed on BSE.
- CPLBSEChemo-Pharma Laboratories Inc.4.02BMarket Cap-2.17%52-week change14.22P/E (Trailing)‪6.56%‬Profit Margin
- ASHOKLEYBSEAshok Leyland Ltd.1.02TMarket Cap+24.58%52-week change31.23P/E (Trailing)‪6.39%‬Profit Margin
- ESCORTSBSEEscorts Kubota Ltd.341.00BMarket Cap-15.72%52-week change27.21P/E (Trailing)‪22.03%‬Profit Margin
- CUBBSECity Union Bank Ltd.219.36BMarket Cap+32.84%52-week change15.34P/E (Trailing)‪37.79%‬Profit Margin
- ACEBSEAction Construction Equipment Ltd.137.42BMarket Cap+9.63%52-week change32.25P/E (Trailing)‪12.79%‬Profit Margin
- OLECTRABSEOlectra Greentech Ltd.106.48BMarket Cap-23.42%52-week change60.89P/E (Trailing)‪2.00%‬Profit Margin
- HMTBSEHMT Ltd.77.38BMarket Cap+11.23%52-week change5.91P/E (Trailing)‪-128.93%‬Profit Margin
Profile Summary - CPL - Chemo-Pharma Laboratories Inc.
About
Chemo-Pharma Laboratories Inc. is a prominent player in the pharmaceutical manufacturing industry, focused on the development and production of high-quality pharmaceutical products. This company specializes in creating a wide array of generic drugs and active pharmaceutical ingredients, serving a global clientele that…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
